| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5900333 | Diabetes Research and Clinical Practice | 2012 | 5 Pages |
Abstract
We examined possible anticancer effects of thiazolidinediones (TZDs) in 6074 Chinese with Type 2 diabetes free of cancer at enrolment. During a median follow-up of 4.93Â years, 270 patients developed cancer. Use of TZDs was associated with reduced risk of cancer in a dose-response manner in multivariable analysis.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Endocrinology
Authors
Xilin Yang, Wing-Yee So, Ronald C.W. Ma, Linda W.L. Yu, Alice P.S. Kong, Heung Man Lee, Gang Xu, Risa Ozaki, Gary T.C. Ko, Juliana C.N. Chan,